The pharmaceutical laboratory Almirall earned 30.9 million in the first quarter of the year, 57.1% more than a year earlier. The company, which announced a dividend of 0.19 euros per share, is confident of meeting its estimates for the whole year.
Almirall improves its profit and relies on its estimates
